Clinical significance of vascular endothelial growth factor and endothelin-1 in serum levels as novel indicators for predicting the progression of diabetic nephropathy
Objective: Early diagnosis and intervention of diabetic nephropathy (DN) is necessary to optimize therapy in order to delay the progression of diabetes. This research aimed to reveal the change of vascular endothelial growth factor (VEGF) and endothelin-1 (ET-1) in patients with DN, and to assess po...
Main Authors: | Wei Chu, Lin-Lin Ma, Bin-Xian Li, Ming-Cheng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | European Journal of Inflammation |
Online Access: | https://doi.org/10.1177/1721727X231151526 |
Similar Items
-
Vascular endothelial growth factor expression in diabetic nephropathy; a clinico-pathological study
by: Sagarika Sharma, et al.
Published: (2021-04-01) -
Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells
by: Koon-Chu Yaiw, et al.
Published: (2021-05-01) -
Serum Aldosterone Levels in Patients With Diabetic Nephropathy in Relation to Vascular Calcification
by: Balqes Hisham Salih, et al.
Published: (2019-06-01) -
Elevated ACE Levels Indicate Diabetic Nephropathy Progression or Companied Retina Impaired
by: Kangkang Huang, et al.
Published: (2022-05-01) -
Increased serum asprosin is correlated with diabetic nephropathy
by: Rui Wang, et al.
Published: (2021-05-01)